Weight loss in obese patients with heart failure

Journal of the American Heart Association

Volumn 5, Issue 3, 2015, Pages

  Zamora, Elisabet ^a,b   Díez López, Carles ^a   Lupón, Josep ^a,b   de Antonio, Marta ^a   Domingo, Mar ^a   Santesmases, Javier ^a   Troya, María Isabel ^a   Díez Quevedo, Crisanto ^a,b   Altimir, Salvador ^a   Bayes Genis, Antoni ^a,b  

^a HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Cachexia; Heart failure; Mortality; Obesity; Weight

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LOOP DIURETIC AGENT; MINERALOCORTICOID ANTAGONIST;

AGED; ARTICLE; BODY MASS; CARDIAC RESYNCHRONIZATION THERAPY; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE DURATION; FEMALE; FOLLOW UP; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEW YORK HEART ASSOCIATION CLASS; OBESITY; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; WEIGHT REDUCTION; CHI SQUARE DISTRIBUTION; EPIDEMIOLOGY; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOPHYSIOLOGY; PROPORTIONAL HAZARDS MODEL; RISK ASSESSMENT; RISK FACTOR; SPAIN; TIME FACTOR; TREATMENT OUTCOME;

AGED; BODY MASS INDEX; CHI-SQUARE DISTRIBUTION; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OBESITY; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; RISK FACTORS; SPAIN; TIME FACTORS; TREATMENT OUTCOME; WEIGHT LOSS;

EID: 85006217727     PISSN: None     EISSN: 20479980     Source Type: Journal    
DOI: 10.1161/JAHA.115.002468     Document Type: Article

References (37)

1. Kenchaiah S, Evans JC, Levy D, Wilson PW, Benjamin EJ, Larson MG, Kannel WB, Vasan RS. Obesity and the risk of heart failure. N Engl J Med. 2002;347:305-313.
2. Calle EE, Thun MJ, Petrelli JM, Rodriguez C, Heath CW Jr. Body-mass index and mortality in a prospective cohort of U.S. adults. N Engl J Med. 1999;341:1097- 1105.
3. Oreopoulos A, Padwal R, Kalantar-Zadeh K, Fonarow GC, Norris CM, McAlister FA. Body mass index and mortality in heart failure: a meta-analysis. Am Heart J. 2008;156:13-22.
4. Padwal R, McAlister FA, McMurray JJV, Cowie MR, Rich M, Pocock S, Swedberg K, Maggioni A, Gamble G, Ariti C, Earle N, Whalley G, Poppe KK, Doughty RN, Bayes-Genis A; Meta-analysis Global Group in Chronic Heart Failure (MAGGIC). The obesity paradox in heart failure patients with preserved versus reduced ejection fraction: a meta-analysis of individual patient data. Int J Obes. 2014;38:1110-1114.
5. Zamora E, Lupón J, Urrutia A, González B, Mas D, Pascual T, Domingo M, Valle V. Does body mass index influence mortality in patients with heart failure? Rev Esp Cardiol. 2007;60:1127-1134.
6. Zamora E, Lupón J, Urrutia A, Bayes-Genis A. Obesity and long-term prognosis in heart failure: the paradox persists. Rev Esp Cardiol. 2010;63: 1210-1212.
7. Shah R, Gayat E, Januzzi JL Jr, Sato N, Cohen-Solal A, diSomma S, Fairman E, Harjola VP, Ishihara S, Lassus J, Maggioni A, Metra M, Mueller C, Mueller T, Parenica J, Pascual-Figal D, Peacock WF, Spinar J, van Kimmenade R, Mebazaa A; GREAT (Global Research on Acute Conditions Team) Network. Body mass index and mortality in acutely decompensated heart failure across the world: a global obesity paradox. J Am Coll Cardiol. 2014;63:778-785.
8. Kenchaiah S, Pocock SJ, Wang D, Finn PV, Zornoff LA, Skali H, Pfeffer MA, Yusuf S, Swedberg K, Michelson EL, Granger CB, McMurray JJ, Solomon SD; CHARM Investigators. Body mass index and prognosis in patients with chronic heart failure: insights from the Candesartan in Heart Failure: assessment of reduction in mortality and morbididty (CHARM) program. Circulation. 2007;116:627-636.
9. Horwich TB, Broderick S, Chen L, McCullough PA, Strzelczyk T, Kitzman DW, Fletcher G, Safford RE, Ewald G, Fine LJ, Ellis SJ, Fonarow GC. Relation among body mass index, exercise training, and outcomes in chronic systolic heart failure. Am J Cardiol. 2011;108:1754-1759.
10. Keys A, Fidanza F, Karvonen MJ, Kimura N, Taylor HL. Indices of relative weight and obesity. J Chronic Dis. 1972;25:329-343.
11. Keys A, Fidanza F, Karvonen MJ, Kimura N, Taylor HL. Indices of relative weight and obesity. Int J Epidemiol. 2014;43:655-665.
12. Clark AL, Fonarow GC, Horwich TB. Waist circumference, body mass index, and survival in systolic heart failure: the obesity paradox revisited. J Card Fail. 2011;17:374-380.
13. Puig T, Ferrero-Gregori A, Roig E, Vazquez R, Gonzalez-Juanatey JR, Pascual- Figal D, Delgado J, Alonso-Pulpon L, Borras X, Mendez A, Cinca J; REDINSCOR Researchers. Prognostic value of body mass index and waist circumference in patients with chronic heart failure (Spanish REDINSCOR Registry). Rev Esp Cardiol. 2014;67:101-106.
14. Futter JE, Cleland JG, Clarck AL. Body mass indices and outcomes in patients with chronic heart failure. Eur J Heart Fail. 2011;13:207-213.
15. Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Drazner MH, Fonarow GC, Geraci SA, Horwich T, Januzzi JL, Johnson MR, Kasper EK, Levy WC, Masoudi FA, McBride PE, McMurray JJ, Mitchell JE, Peterson PN, Riegel B, Sam F, Stevenson LW, Tang WH, Tsai EJ, Wilkoff BL. 2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation. 2013;128:1810-1852.
16. McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Böhm M, Dickstein K, Falk V, Filippatos G, Fonseca C, Gomez-Sanchez MA, Jaarsma T, Køber L, Lip GY, Maggioni AP, Parkhomenko A, Pieske BM, Popescu BA, Rønnevik PK, Rutten FH, Schwitter J, Seferovic P, Stepinska J, Trindade PT, Voors AA, Zannad F, Zeiher A; ESC Committee for Practice Guidelines. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2012;33:1787-1847.
17. Lavie CJ, Alpert MA, Ventura HO. Risks and benefits of weight loss in heart failure. Heart Fail Clin. 2015;11:125-131.
18. Clark AL, Fonarow GC, Horwich TB. Obesity and the obesity paradox in heart failure. Prog Cardiovasc Dis. 2014;56:409-414.
19. Lavie CJ, Alpert MA, Arena R, Mehra MR, Milani RV, Ventura HO. Impact of obesity and the obesity paradox on prevalence and prognosis in heart failure. JACC Heart Fail. 2013;1:93-102.
20. Alpert MA, Omran J, Mehra A, Ardhanari S. Impact of obesity and weight loss on cardiac performance and morphology in adults. Prog Cardiovasc Dis. 2014;56:391-400.
21. Zamora E, Lupón J, Vila J, Urrutia A, de Antonio M, Sanz H, Grau M, Ara J, Bayés-Genís A. Estimated glomerular filtration rate and prognosis in heart failure: value of the MDRD-4, CDK-EPI, and Cockroft-Gault formulas. J Am Coll Cardiol. 2012;59:1709-1715.
22. Gastelurrutia P, Lupón J, de Antonio M, Urrutia A, Díez C, Coll R, Altimir S, Bayes-Genis A. Statins in heart failure: the paradox between large randomized clinical trials and real life. Mayo Clin Proc. 2012;87:555-560.
23. Banack HR, Kaufman JS. The "obesity paradox" explained. Epidemiology. 2013;24:461-462.
24. Zamora E, Lupón J, de Antonio M, Urrutia A, Coll R, Díez C, Altimir S, Bayés- Genís A. The obesity paradox in heart failure: is etiology a key factor? Int J Cardiol. 2013;166:601-605.
25. Aktas MK, Zareba W, Huang DT, McNitt S, Polonsky S, Chen L, Stockburger M, Merkely B, Moss AJ, Kutyifa V. The effect of weight loss on clinical outcomes in patients implanted with a cardiac resynchronization therapy device-A MADITCRT substudy. J Card Fail. 2014;20:183-189.
26. Adamopoulos C, Meyer P, Desai RV, Karatzidou K, Ovalle F, White M, Aban I, Love TE, Deedwania P, Anker SD, Ahmed A. Absence of obesity paradox in patients with chronic heart failure and diabetes mellitus: a propensity-matched study. Eur J Heart Fail. 2011;13:200-206.
27. Nochioka K, Shiba N, Kohno H, Miura M, Shimokawa H. Both high and low body mass indexes are prognostic risks in Japanese patients with chronic heart failure: implications from the CHART study. J Card Fail. 2010;16:880- 887.
28. Gastelurrutia P, Lupón J, Domingo M, Ribas N, Noguero M, Martinez C, Cortes M, Bayes-Genis A. Usefulness of body mass index to characterize nutritional status in patients with heart failure. Am J Cardiol. 2011;108: 1166-1170.
29. Mariotti R, Castrogiovanni F, Canale ML, Borelli G, Rondinini L. Weight loss and quality of life in chronic heart failure patients. J Cardiovasc Med (Hagerstown). 2008;9:576-580.
30. Beck-da-Silva L, Higginson L, Fraser M, Williams K, Haddad H. Effect of Orlistat in obese patients with heart failure: a pilot study. Congest Heart Fail. 2005;11:118-123.
31. Anker SD, Negassa A, Coats AJ, Afzal R, Poole-Wilson PA, Cohn JN, Yusuf S. Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study. Lancet. 2003;361:1077-1083.
32. Rossignol P, Masson S, Barlera S, Girerd N, Castelnovo A, Zannad F, Clemenza F, Tognoni G, Anand IS, Cohn JN, Anker SD, Tavazzi L, Latini R; GISSI-HF and Val-HeFT Investigators. Loss in body weight is an independent prognostic factor for mortality in chronic heart failure: insights from the GISSI-HF and Val- HeFT trials. Eur J Heart Fail. 2015;17:424-433.
33. Pureza V, Florea VG. Mechanisms for cachexia in heart failure. Curr Heart Fail Rep. 2013;10:307-314.
34. Song EK, Lee Y, Moser DK, Dekker RL, Kang SM, Lennie TA. The link of unintentional weight loss to cardiac event-free survival in patients with heart failure. J Cardiovasc Nurs. 2014;29:439-447.
35. Pocock SJ, McMurray JJ, Dobson J, Yusuf S, Granger CB, Michelson EL, Ostergren J, Pfeffer MA, Solomon SD, Anker SD, Swedberg KB. Weight loss and mortality risk in patients with chronic heart failure in the Candesartan in Heart Failure: assessment of reduction in mortality and morbidity (CHARM) programme. Eur Heart J. 2008;29:2641-2650.
36. Trullàs JC, Formiga F, Montero M, Carrera-Izquierdo M, Grau-Amorós J, Chivite- Guillén D, Manzano L; RICA Investigators. Impact of weight loss on mortality in chronic heart failure: findings from the RICA Registry. Int J Cardiol. 2013;168:306-311.
37. Lavie CJ, Berra K, Arena R. Formal cardiac rehabilitation and exercise training programs in heart failure: evidence for substantial clinical benefits. J Cardiopulm Rehabil Prev. 2013;33:209-211.